No Data
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
Everbright: Import substitution is expected to accelerate, pay attention to the rising market share of domestic surgical robots.
Everbright stated that the import substitution is expected to accelerate, paying attention to the rise in market share of domestic surgical robots.
China Securities Co.,Ltd.: It is recommended to focus on the new growth and integration opportunities in the Industry.
China Securities Co.,Ltd. remains bullish on high-quality Innovative Drugs companies in 2025 and actively focuses on cutting-edge technologies in pharmaceuticals and medical devices.
Xianruida Medical-B (06669.HK) reported a profit of 52.28 million yuan for 2024, representing a year-on-year increase of 260.9%.
On March 24, Glory Exchange announced that, for the fiscal year ending December 31, 2024, the company's revenue is approximately RMB 0.534 billion, an increase of about 12.7% year-on-year. The profit for the year is 52.28 million yuan, an increase of 260.9% year-on-year; earnings per share are 0.17 yuan. In 2024, the company continues to drive innovation and iteration in technology and processes, making significant progress in product development. During the reporting period, three products have completed product finalization, two products are undergoing clinical trials, and six products have submitted registration applications to the National Medical Products Administration.
ACOTEC-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Tell The Story For Acotec Scientific Holdings Limited (HKG:6669) As Its Stock Soars 35%
